Probing the endothelial function of THY1 in vivo, the group injected breast cancer cells and CAF into mice, along with snippets of DNA that silence expression of THY1. When they stained for CD11b, a ...

also known as GB1275—an experimental oral pancreatic cancer medication that also reduces the number of immune-suppressing cells that enter a tumor. The drug serves as a regulator of CD11b ...

for T-cell markers; RB6-8C5 (GR-1) and M1/70 (CD11b, Mac-1) for myeloid markers; PK136 (NK1.1) for natural killer cells; and Ter119 for erythrocytes. The positively selected cells were also ...